|
Dec 21
|
Will Eli Lilly's Emergency Diabetes Drug Give Amphastar Wings?
|
|
Dec 21
|
Eli Lilly cut to Outperform at Daiwa Securities: 4 big analyst cuts
|
|
Dec 20
|
2 Unstoppable Growth Stocks to Buy in 2024
|
|
Dec 20
|
These 2 Unstoppable Stocks Could Make You Richer in 2024 and Beyond
|
|
Dec 20
|
3 Top Dividend Stocks That Recently Hiked Their Payouts
|
|
Dec 19
|
Shipping Attacks, Weight Loss Wonder Drugs, Lilly Stock Analysis, Trading Apple
|
|
Dec 19
|
The Zacks Analyst Blog Highlights Novo Nordisk, Eli Lilly, Vertex Pharmaceuticals, Regeneron and GSK
|
|
Dec 18
|
Structure Plummets 43% After Trailing Lilly In Obesity Treatment
|
|
Dec 18
|
New Shakeup Hits Obesity Pills. Structure Rolls Out Disappointing Data.
|
|
Dec 18
|
5 Big Drug Stocks That May Continue to Outperform in 2024
|
|
Dec 18
|
Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 22, 2023
|
|
Dec 18
|
Point radiopharma drug results disappoint in prostate cancer study
|
|
Dec 10
|
12 Healthcare Stocks Billionaires Like the Most
|
|
Dec 10
|
Bearish Bets: 3 Stocks You Should Consider Shorting This Week
|
|
Dec 10
|
3 Unstoppable Stocks to Buy Right Now
|
|
Dec 8
|
Eli Lilly (LLY) Rises Higher Than Market: Key Facts
|
|
Dec 8
|
Lilly Announces 15% Dividend Increase, First-Quarter 2024 Dividend
|
|
Dec 8
|
Pharma Stock Roundup: ABBV to Buy CERE, JNJ's 2024 View, LLY & NVS Get FDA Nod
|
|
Dec 8
|
Positive News Drove Eli Lilly and Company (LLY) in Q3
|
|
Dec 8
|
Could Eli Lilly Beat Novo Nordisk in the Billion-Dollar Weight Loss Market?
|